Russia Moves To Free Foreign Drugs From Repeated Clinical Trials
This article was originally published in PharmAsia News
Russia’s Federal Antimonopoly Service said it is considering law changes that would free foreign drugs that already have undergone suitable clinical trials from having to go through new trials in Russia.
You may also be interested in...
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.